BFC Ocularis

For ophthalmic use only. Tilt head back, pull down the lower eyelid to form a pocket, instill one drop, then gently close the eye. Avoid touching the dropper tip to the eye or any other surface. If more than one ophthalmic medication is used, administer at least 5 minutes apart.

Bromfenac inhibits prostaglandin synthesis by interfering with the cyclooxygenase (COX-1 and COX-2) enzymes. Prostaglandins are mediators of inflammation and pain, so inhibiting their synthesis reduces these symptoms in the eye.

• Hypersensitivity to Bromfenac or any components of the formulation.
• Hypersensitivity to other NSAIDs (e.g., aspirin, ibuprofen) as cross-sensitivity may occur.
• Patients with bleeding disorders.

Store at room temperature (20°C to 25°C). Protect from light. Do not freeze.

An overdose is unlikely with topical ophthalmic administration. If accidentally ingested, symptomatic and supportive treatment may be considered. Eye irritation from excessive topical use can be managed by rinsing the eye with lukewarm water.

Pregnancy Category C. Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Caution is advised when administered to a nursing mother. Consult a doctor.

• Hypersensitivity to Bromfenac or any components of the formulation.
• Hypersensitivity to other NSAIDs (e.g., aspirin, ibuprofen) as cross-sensitivity may occur.
• Patients with bleeding disorders.

Store at room temperature (20°C to 25°C). Protect from light. Do not freeze.

An overdose is unlikely with topical ophthalmic administration. If accidentally ingested, symptomatic and supportive treatment may be considered. Eye irritation from excessive topical use can be managed by rinsing the eye with lukewarm water.

Pregnancy Category C. Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Caution is advised when administered to a nursing mother. Consult a doctor.